Nitta Gelatin India Ltd

Nitta Gelatin Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nitta Gelatin India Ltd

₹ 897 2.11%
31 Oct - close price
gelatin.in BSE: 506532
About

Incorporated in 1975, Nitta Gelatin India Ltd manufactures and sells ossein, gelatin, and collagen peptide[1]

Key Points

Business Overview:[1]
NGIL, a joint venture between the Kerala State Industrial Development Corporation (32% shareholding) and Osaka-based NGI (43% stake), manufactures gelatin, ossein, limed ossein, and DCP from processed animal bones. It also produces collagen peptide-based consumer products for the pharmaceutical and healthcare industries.

Website BSE
  • Market Cap ₹ 814 Cr.
  • Current Price ₹ 897
  • High / Low ₹ 1,005 / 640
  • Stock P/E 10.0
  • Book Value ₹ 474
  • Dividend Yield 0.67 %
  • ROCE 25.7 %
  • ROE 20.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 56.1% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.4%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
125 119 130 116 123 118 115 131 132 135 129 139 138
104 89 107 82 97 91 93 104 107 108 106 111 112
Operating Profit 21 31 23 34 27 27 22 28 25 27 23 27 26
OPM % 17% 26% 17% 29% 22% 23% 19% 21% 19% 20% 18% 20% 19%
5 0 0 2 9 0 5 2 4 9 6 2 11
Interest 2 1 0 0 0 0 2 0 0 1 1 1 1
Depreciation 3 3 3 3 4 4 4 3 3 3 3 3 4
Profit before tax 20 27 19 33 32 23 22 26 26 32 26 26 33
Tax % 23% 22% 28% 25% 21% 29% 26% 26% 25% 25% 25% 25% 20%
16 21 14 24 25 17 16 19 20 24 19 19 26
EPS in Rs 17.34 22.85 15.23 26.97 27.63 18.29 17.94 21.19 21.51 26.73 21.11 21.35 28.79
Raw PDF
Upcoming result date: today

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
287 355 357 341 343 261 294 354 429 487 473 527 541
277 329 318 304 316 243 268 314 378 397 363 424 437
Operating Profit 10 27 39 37 27 18 27 40 51 90 110 104 103
OPM % 3% 8% 11% 11% 8% 7% 9% 11% 12% 18% 23% 20% 19%
0 2 2 9 5 1 3 5 6 5 17 22 29
Interest 6 8 6 4 7 8 8 5 5 4 3 3 2
Depreciation 11 10 9 10 14 14 15 15 14 13 14 13 14
Profit before tax -7 10 26 32 11 -4 7 24 38 78 110 110 117
Tax % -32% 49% 37% 36% 65% -28% -15% 26% 29% 25% 25% 25%
-5 5 17 20 4 -3 8 18 27 59 82 82 89
EPS in Rs -5.46 5.62 18.38 22.57 4.16 -2.91 8.70 19.72 29.30 64.72 90.86 90.55 97.98
Dividend Payout % -0% 18% 14% 11% 60% -52% 29% 15% 14% 12% 7% 9%
Compounded Sales Growth
10 Years: 4%
5 Years: 12%
3 Years: 7%
TTM: 9%
Compounded Profit Growth
10 Years: 30%
5 Years: 56%
3 Years: 40%
TTM: 13%
Stock Price CAGR
10 Years: 21%
5 Years: 43%
3 Years: 18%
1 Year: 13%
Return on Equity
10 Years: 16%
5 Years: 22%
3 Years: 25%
Last Year: 21%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 9 9 9 9 9 9 9 9 9 9 9 9 9
Reserves 106 113 125 130 138 133 134 154 176 231 307 383 421
53 53 70 84 104 101 79 75 80 33 27 45 36
42 40 45 48 55 51 53 49 51 53 57 54 62
Total Liabilities 210 214 249 271 305 295 276 287 316 326 400 492 528
82 77 80 77 110 126 116 108 102 109 106 111 144
CWIP 8 8 7 11 10 3 4 2 7 7 8 19 5
Investments 32 32 45 27 4 4 4 4 4 5 5 5 5
88 96 117 157 181 161 151 172 202 206 281 357 375
Total Assets 210 214 249 271 305 295 276 287 316 326 400 492 528

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
23 17 29 11 26 28 33 15 13 78 79 61
-24 -8 -22 -3 -7 -13 -7 -3 -11 -15 -44 2
0 -8 11 -6 -20 -14 -29 -12 -2 -53 -15 11
Net Cash Flow -0 1 18 2 -0 1 -3 -0 -1 10 20 74

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 28 23 21 56 65 74 34 57 65 59 60 66
Inventory Days 129 99 112 127 151 202 220 161 148 133 164 138
Days Payable 80 50 43 37 56 67 58 46 30 45 53 38
Cash Conversion Cycle 77 72 90 147 160 210 196 172 182 148 171 165
Working Capital Days 6 17 18 35 29 18 18 50 52 72 82 75
ROCE % -1% 11% 17% 17% 7% 2% 6% 13% 17% 31% 37% 26%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
74.49% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
0.12% 0.26% 0.26% 0.12% 0.12% 0.12% 0.12% 0.12% 0.08% 0.09% 0.35% 0.64%
25.41% 25.26% 25.26% 25.41% 25.40% 25.40% 25.39% 25.40% 25.45% 25.43% 25.17% 24.89%
No. of Shareholders 8,6508,3328,46610,18311,02811,57311,78312,22912,23912,07811,57411,248

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings